Skip to main content

Material Jetting Companies

15 Bioprinting · Material Jetting companies in the additive manufacturing ecosystem tracked by AMPulse. Browse profiles, funding rounds, and technology details.

Updated

Material Jetting (MJT) is Material Jetting — droplets of photopolymer are jetted and UV-cured; enables full-color, multi-material parts with micron accuracy. AMPulse tracks 15 companies using Material Jetting as a core technology, ranked below by total funding raised.

Typical materials: photopolymer resins, rubber-like, rigid, full-color. Common applications: anatomical models, consumer prototypes, molds and patterns.

Market structure

Material Jetting (MJT) deposits droplets of photopolymer resin via inkjet printheads and cures each layer with UV light, enabling true full-color, multi-material parts with layer thicknesses as low as 14μm. The process is the most capable AM technology for combining rigid, flexible, transparent, and pigmented materials in a single build — critical for anatomical models, consumer product prototypes, and design verification where visual realism matters. MJT trades cost (resin price + waste) and part durability (photopolymers age under UV) for fidelity. The dominant commercial application is medical surgical planning: hospitals and medical device companies use multi-material MJT to create patient-specific anatomical models that combine bone, soft tissue, and vasculature in surgically realistic forms.

Key players

Stratasys dominates the high end with the J-series (J55, J735, J826, J850 Pro) and the Connex line (legacy Objet, acquired in 2012). The PolyJet trademark is essentially synonymous with industrial MJT. Mimaki (Japan) competes with the UJF series, particularly strong in graphic and design applications where full-color matters. Photocentric uses MJT-adjacent LCD technology. 3D Systems' MJP (MultiJet Printing) line is positioned more toward dental/jewelry casting patterns than full-color. The barrier to entry is high — MJT requires inkjet printhead engineering plus photochemistry plus precision motion, a combination only a few companies have integrated successfully.

Recent dynamics

Three trends are notable. First, medical adoption is accelerating: Stratasys has explicitly targeted radiologists and surgical planners, with formal FDA guidance on patient-specific anatomical models lowering regulatory friction. Second, mass-customization in consumer products (eyewear, footwear inserts, cosmetic packaging prototypes) is a steady but underappreciated growth segment. Third, the dental aligner market — historically dominated by SLA — has barely touched MJT due to material cost concerns; this could change if Stratasys develops more cost-competitive aligner-grade resins.

Forward outlook

MJT's growth is tied to two distinct adoption curves: medical surgical planning (steady, regulatory-friction-limited) and consumer product prototyping (cyclical with industrial design budgets). The technology is unlikely to expand beyond high-fidelity prototyping into pure production due to per-part economics, but its niche is durable. Material innovation — particularly biocompatible and engineering-thermoset photopolymers — will determine whether MJT can address production-grade applications.

Ourobionics

Develops the CHIMERA 5-in-1 biofabrication platform for 4D bioprinting of human tissues with embedded biosensors and bioelectronics, enabling high-throughput production for regenerative medicine and drug testing.

Wageningen, NetherlandsFounded 2021$455.22M

Cyfuse

Develops and sells the Regenova bio 3D printer system, which fabricates three-dimensional tissues and organs using a scaffold-free, needle-array-based 'Kenzan Method' for regenerative medicine applications.

Minato-ku, Tokyo, JapanFounded 2010$24.5M

OxSyBio

Develops droplet-based 3D bioprinting technology to produce synthetic tissue-like materials for regenerative medicine, wound healing, and drug delivery applications.

Oxford, United KingdomFounded 2014$16.4M

VIVAX BIO

Develops 3D bioprinters and bioprinted tissue constructs for medical research and cultivated meat, including the FABION bioprinter and in situ portable systems.

New York, NY, USAFounded 2013$5.2M

Roslin Cellab

Provides contract research, product development, and stem cell culture training using 3D bioprinting for drug testing and regenerative medicine applications.

Edinburgh, Scotland, UKFounded 2016£4.44M

Frontier Bio

Develops the FLUX-1 bioprinter and lab-grown human tissues (e.g., lung, blood vessels) using electro-hydrodynamic printing (EHDP) and conventional bioprinting technologies for regenerative medicine and animal testing alternatives.

Hayward, CA, USAFounded 2018$4.1M

Clecell

Develops and commercializes 3D bioprinters (U-FAB series) and bioinks (Celluid series) for tissue engineering and regenerative medicine, enabling precise layering of low-viscosity biomaterials.

Seongnam-si, South KoreaFounded 2017$2.5M

Biological Lattice Industries

Develops AI-enabled 3D bioprinting platforms (BioLoom hardware and Loominus Studio software) to simplify biofabrication for life sciences R&D, enabling automated design, fabrication, and testing of biomaterials.

Boston, MA, USAFounded 2021$1.8M

TissueLabs

Develops a biofabrication platform integrating 3D bioprinters and tissue-specific biomaterials for creating lab-grown tissues and organs, accelerating research in drug discovery, disease modeling, and regenerative medicine.

Manno, SwitzerlandFounded 2019$1.1M

Copner Biotech

Develops proprietary GRAPE® software and bioprinting systems for high-precision 3D cell culture scaffolds and tissue engineering, enabling additive manufacturing of accurate, repeatable biological models.

Ebbw Vale, United KingdomFounded 2020$715K

BIO INX

Develops and commercializes high-performance bio-inks and materials for 3D bioprinting and biofabrication applications.

Ghent, BelgiumFounded 2018€700K

Jetbio

Jetbio offers 3D bioprinting systems that utilize patented Reactive Jet Impingement (ReJI) technology to print high cell density, human-like tissue models for drug discovery and regenerative medicine.

Newcastle upon Tyne, UKFounded 2023£650K

Chiron Biotech

Develops a fast multimaterial inkjet bioprinting platform for biomedical research and production, enabling creation of complex biomimetic tissues with high speed and resolution.

NetherlandsFounded 2022$58.3K

UPM Biomedicals

Develops wood-based nanofibrillar cellulose hydrogels and bioinks for 3D bioprinting and cell culture, enabling sustainable, animal-free biomedical applications like tissue engineering and drug development.

Helsinki, FinlandFounded 1996Undisclosed

Black Drop Biodruker

Develops modular 3D bioprinters and specialized bioinks for creating living tissues and organ-like structures, enabling researchers to advance medical treatments without the complexity of traditional systems.

Aachen, Germany (Headquarters), Porto, Portugal (Office)Founded 2017

Frequently asked questions

What is Material Jetting (MJT)?

Material Jetting — droplets of photopolymer are jetted and UV-cured; enables full-color, multi-material parts with micron accuracy.

Which companies are leaders in Material Jetting?

Based on funding data tracked by AMPulse as of 2026-05, the top Material Jetting companies include Ourobionics, Cyfuse, OxSyBio, VIVAX BIO, and Roslin Cellab. Full list of 15 tracked companies available on this page.

What materials does Material Jetting use?

Material Jetting commonly works with photopolymer resins, rubber-like, rigid, full-color.

What industries use Material Jetting?

Primary applications for Material Jetting include anatomical models, consumer prototypes, molds and patterns.